It’s not the fountain of youth but it may just be the next best thing. Protandim is a unique blend of phytonutrients that has been shown in a published, peer reviewed human study to eliminate the age-related increase in cell aging factors. The groundbreaking pill supplement, tested in clinical trials by noted scientist Dr. Joe McCord and featured on ABC’s Prime Time Live, reduces the toxins associated with aging and may potentially benefit in combating ailments and diseases.
The differences between Protandim and your garden variety supplements and vitamins are so pronounced that they shouldn’t even be in the same sentence together. Protandim confronts the body’s aging processes with a scalpel’s precision, directly targeting the bio-chemical indicators of getting older. Protandim is made from five natural ingredients; silymarin from milk thistle, bacopa extract, Ashwagandha, green tea extract and curcumin from turmeric.
What Protandim Targets
From fading colors in clothes to paint that begins to chip, we can actually see the signs of something getting older. Yet the body also has an internal way of chronicling its aging, and we can observe our own fading and chipping in the form of TBARS (thiobarbituric acid-reactive substances). TBARS are the toxins in your blood produced by the free-radicals in your cells. The sum of these TBARS has a direct correlation to the rate at which you age; as we get older, the amount of TBARS increases.
Stopping Free-Radicals
Not only does Protandim throw up a stop sign to the TBARS by freezing the increase in toxins, it actually reduces our TBARS level, effectively hitting the rewind button on our toxic stress level. In fact, many adults taking Portandim will see their TBARS level revert to the stress quotient that a baby would have.
Protandim actually signals the cells in your body to produce its own antioxidants enzymes, which provide thousands of times more antioxidant power than any food or conventional supplement. More enzymes results in fewer of the free-radicals that harm the body.
Protandim’s Clinical Trials
Dr. Joe McCord conducted the clinical trials of Protandim by measuring the TBARS in men and women of a variety of ages. The amount of TBARS in their blood was consistent with their age; the older the subject, the higher number of TBARS in their blood.
Test subjects took one Protandim pill each day as part of the study. After 30 days, the study revealed that TBARS levels in the study’s subjects achieved an average decrease of 40 percent in TBARS, equivalent to the aging rate of a 20 year old.
Dr. McCord’s study validated that the precise combination of natural phytonutrients in the patented Protandim formula consistently and significantly boosted the body’s own production of two protective antioxidant enzymes, SOD (superoxide dismutase) and CAT (catalase). These two antioxidant enzymes are fundamental to neutralizing the cell-damaging free radicals associated with aging and a variety of health conditions.
Reducing Inflammation
Protandim was issued its third patent on August 25, 2009 from the United States Patent and Trademark Office. The patent acknowledges Protandim’s effectiveness in reducing important inflammation Bio-marker C-reactive Protein. Suffering from elevated basal levels of C-reactive protein is considered a risk factor for diabetes, hypertension, and cardiovascular disease.
In response to the additional patent, Dr. McCord said “This patent further underscores the unique and powerful actions of Protandim as a tool against not only oxidative stress, but also inflammation. Chronic, low-level inflammation is now known to be associated with many of the major diseases we face as we age, including atherosclerosis, diabetes, obesity, and neurodegenerative diseases.”
Potential for Fighting Diseases
Inspired by Protandim’s dramatic effect on the level of TBARS, scientists and academics have made Protandim the subject of over 20 current scientific studies at leading universities and research facilities including Ohio State University, University of Minnesota, Virginia Commonwealth, Children’s Hospital Denver, Vanderbilt University, University of Florida, University of Michigan, University of Kentucky, Louisiana State University, Denver Health Medical Center, and University of Colorado.
These studies are researching Protandim’s potential for fighting disease. The diseases being studied include skin cancer, photoaging of the skin, renal failure, osteoarthritis, HIV/AIDS, pulmonary hypertension, periodontal disease, heart disease, asthma, coronary artery bypass graft failure, muscular dystrophy, optic neuropathy, non-alcoholic fatty liver disease, and metabolic syndrome.
Purchasing Protandim
Protandim can be purchased for 40 dollars a month at www.ProvenYouthScience.com.
To learn more about Protandim studies, visit
View the ABC Prime Time Live feature on Protandim and Dr. McCord on YouTube, .
